The Multifaceted Parvoviridae Family: From Pathogens to Therapeutics
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Vaccines and Therapeutic Developments".
Deadline for manuscript submissions: closed (1 December 2023) | Viewed by 29074
Special Issue Editors
Interests: parvoviruses; oncolytic viruses; cancer; cancer virotherapy; cancer viroimmunotherapy
Special Issue Information
Dear Colleagues,
Parvoviridae is a family of small (23–28 nm), non-enveloped viruses with an icosahedral capsid, which encloses a linear single-stranded 4-6 kb DNA genome flanked on both ends by short terminal hairpins. The family includes three subfamilies, twenty-three genera, and more than a hundred virus species. Notably, some of these viruses are animal or human pathogens, while others are used for gene therapy and oncolytic virus therapy purposes. This Special Issue of Pathogens aims at bringing together original research and review articles to provide the readers with a comprehensive picture of the multifaceted role of Parvoviridae in both disease induction and treatment. Recent discoveries, current state of the art, challenges, and prospects are discussed, with a particular focus on parvovirus newly identified associations with disease and exciting applications to the therapy of genetic disorders, including cancer.
Dr. Assia Angelova
Prof. Dr. Jean Rommelaere
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- parvoviridae
- gene therapy
- oncolytic virus therapy
- pathogenicity
- genetic disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.